Clinical Trial Update: Study of WVE-003 in Patients With Huntington's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of WVE-003 in Huntington's disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• WVE-003

Snippet

Sponsor: Wave Life Sciences Ltd. | Conditions: Huntington Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-12